Heparin market size to grow to USD 2.29 billion, 37% of market growth to be generated from Europe

Get a comprehensive report summary describing the size and forecast of the Heparin market along with research methodology. sample report Available in PDF format

Heparin Market 2021-2025: Scope

The Heparin market report covers the following sectors:

Get lifetime access to our Technavio Insights! subscribe to us The “Basic Plan” is billed annually USD 5000

Heparin Market 2021-2025: Drivers and Challenges

Increasing prevalence of coagulation disorders Heparin is driving the market growth. Some common coagulation disorders include von Willebrand’s disease, hemophilia, deep venous thrombosis, hypercoagulable states, and clotting factor deficiency. The increasing prevalence of these coagulation disorders requires continuous monitoring for further medical interventions. In addition, physicians recommend coagulation tests during major surgery.

side effects of heparin Heparin will challenge the growth of the market. Bleeding is the main side effect of heparin. Other adverse effects include heparin-induced thrombocytopenia, heparin-associated osteoporosis, skin reactions, eosinophilia, and allergic reactions. Of these, heparin-induced thrombocytopenia and osteoporosis are the most common. Therefore, the use of heparin is decreasing due to its side effects. Moreover, increasing awareness about the side effects of heparin will hinder the growth of the global heparin market.

Heparin Market 2021-2025: Segmentation

  • the product
    • Low Molecular Weight Heparin: The Low Molecular Weight Heparin segment will contribute to the highest market share growth during the forecast period. The adoption of low molecular weight heparin products is expected to increase due to their advantages and efficacy and wide availability during the forecast period.
    • other
  • Geography
    • Europe, Europe This will account for 37% of the market growth during the forecast period. The increasing prevalence of obesity and smoking and high alcohol consumption will drive the growth of the heparin market in the region during the forecast period. uk, GermanyAnd France The major countries for the heparin market in Europe, Moreover, the market growth in this region will be faster than the growth in other regions.
    • North America
    • Asia
    • queue

Heparin Market 2021-2025: Key Highlights

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on the factors that will support the growth of the heparin market during the next five years
  • Estimation of the size of the heparin market and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • Growth of the Heparin Market
  • Analysis of the competitive landscape of the market and detailed seller information
  • Comprehensive description of factors challenging the growth of vendors of the heparin market

related report

Venous Blood Collection Market by Application and Geography – Forecast & Analysis 2022-2026

Hairy Cell Leukemia Therapeutic Market by Product and Geography – Forecast & Analysis 2022-2026

Heparin Market Scope

report coverage

description

page number

120

base year

2020

forecast period

2021-2025

Growth pace and CAGR

Accelerating at a CAGR of 6.06%

Market Growth 2021-2025

USD 2.29 billion

market structure

fragmented

Year on Year Growth (%)

5.75

regional analysis

Europe, North America, Asia and ROW

performance market contribution

Europe 37%

major consumer countries

US, UK, Germany, China and France

competitive landscape

Leading Companies, Competitive Strategies, Scope of Consumer Engagement

Profiled companies

Aspen Pharmacare Holdings Ltd., Baxter International Inc., Isai Co. Ltd., Fresenius SE & Co. KZA, Hikma Pharmaceuticals Plc, Laboratorios Pharmaceuticals Rovi SA, Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, and Viatris Inc.

market dynamics

Basic market analysis, market growth indicators and constraints, fast growing and slow growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period,

range of customization

If our reports don’t include the data you’re looking for, you can contact our analysts and get the segments customized.

Table of Contents:

1. Executive Summary

2 Market Scenario

  • 2.1 Market Ecosystem
    • Exhibit 01: Original Market
    • EXHIBITION 02: MARKET FEATURES
  • 2.2 Value Chain Analysis
    • Exhibit 03: Value Chain Analysis: Pharmaceuticals

3 Market Sizing

  • 3.1 Market Definition
    • Exhibit 04: Sellers’ Offerings Included in the Market Definition
  • 3.2 Market Segment Analysis
    • Exhibit 05: Market Segment
  • 3.4 Market Outlook: Forecast for 2020 – 2025
    • Exhibit 06: Global – Market Size and Forecast 2020 – 2025 ($ million)
    • Exhibit 07: Global Markets: Year-on-Year Growth 2020 – 2025 (%)

4 Analysis of the Five Forces

  • 4.1 Analysis of the Five Forces
    • Exhibit 08: Analysis of the Five Forces 2020 and 2025
  • 4.2 Bargaining Power of Buyers
    • Exhibit 09: Bargaining Power of Buyers
  • 4.3 Bargaining Power of Suppliers
    • Exhibit 10: The Bargaining Power of Suppliers
  • 4.4 Threat of new entrants
    • Exhibit 11: The threat of new entrants
  • 4.5 Danger of Options
    • Exhibit 12: Threats of Choice
  • 4.6 The threat of rivalry
    • Exhibit 13: The Danger of Rivalry
  • 4.7 Market Conditions
    • Exhibit 14: State of the Market – Five Forces 2020

5 Market Segmentation by Product

  • 5.1 Market Segment
    • Exhibit 15: Products – Market Share 2020-2025 (%)
  • 5.2 Comparison by Product
    • Exhibit 16: Comparison by Product
  • 5.3 Low Molecular Weight Heparin – Market Size and Forecast 2020-2025
    • Exhibit 17: Low Molecular Weight Heparin – Market Size and Forecast 2020-2025 ($ million)
  • 5.4 Low Molecular Weight Heparin
    • Exhibit 18: Low Molecular Weight Heparin – Year-on-Year Growth 2020-2025 (%)
  • 5.5 Others – Market Size and Forecast 2020-2025
    • Exhibit 19: Others – Market Size and Forecast 2020-2025 ($ million)
    • Exhibit 20: Others – Year-on-Year Growth 2020-2025 (%)
  • 5.6 Market Opportunity by Product
    • Exhibit 21: Market Opportunity by Product

6 Market Segmentation by Route of Administration

  • 6.1 Market Segment
    • Exhibit 22: Route of Administration – Market Share 2020-2025 (%)
  • 6.2 Comparison by Route of Administration
    • Exhibit 23: Comparison with the Route of Administration
  • 6.3 Subcutaneous Injection – Market Size and Forecast 2020-2025
    • Exhibit 24: Subcutaneous Injection – Market Size and Forecast 2020-2025 ($ million)
    • Exhibit 25: Subcutaneous Injection – Year-on-Year Growth 2020-2025 (%)
  • 6.4 Intravenous/Infusion – Market Size and Forecast 2020-2025
    • Exhibit 26: Intravenous/Infusion – Market Size and Forecast 2020-2025 ($ million)
    • Exhibit 27: Intravenous/Infusion – Year-on-Year Growth 2020-2025 (%)
  • 6.5 Market Opportunities Through Administration
    • Exhibit 28: Market Opportunity by Way of Administration

7 Customer Scenario

  • 7.1 Customer Scenario
    • Exhibit 29: Customer Scenario

8 Geographical Landscapes

  • 8.1 Geographical Division
    • Exhibit 30: Market Share by Geography 2020-2025 (%)
  • 8.2 Geographical Comparison
    • Exhibit 31: Geographical Comparison
  • 8.3 Europe – Market size and forecast 2020-2025
    • Exhibit 32: Europe – Market size and forecast 2020-2025 ($ million)
    • Exhibit 33: Europe – Year-on-Year Growth 2020-2025 (%)
  • 8.4 North America – Market size and forecast 2020-2025
    • Exhibit 34: North America – Market size and forecast 2020-2025 ($ million)
    • Exhibit 35: North America – Year-on-Year Growth 2020-2025 (%)
  • 8.5 Asia – Market size and forecast 2020-2025
    • Exhibit 36: Asia – Market size and forecast 2020-2025 ($ million)
    • Exhibit 37: Asia – Year-on-Year Growth 2020-2025 (%)
  • Line 8.6 – Market Size and Forecast 2020-2025
    • Exhibit 38: Row – Market Size and Forecast 2020-2025 ($ million)
    • Exhibit 39: ROW – Year-on-Year Growth 2020-2025 (%)
  • 8.7 Major Leading Countries
    • Exhibit 40: Major Leading Countries
  • 8.8 Market Opportunities by Geography
    • Exhibit 41: Market Opportunities by Geography ($ million)

9 drivers, challenges and trends

  • 9.2 Market Challenges
    • Exhibit 42: Drivers and Challenges Impact

10 Vendor Landscape

  • 10.1 Overview
    • Exhibit 43: Vendor Landscapes
  • 10.2 Landscape Disruption

11 Vendor Analysis

  • 11.1 Vendors Included
    • Exhibit 46: Vendors Covered
  • 11.2 Market Position of Sellers
    • Exhibit 47: Market Position of Sellers
  • 11.3 Aspen Pharmacare Holdings Limited
    • Exhibit 48: Aspen Pharmacare Holdings Limited – Overview
    • Exhibit 49: Aspen Pharmacare Holdings Limited – Business Segment
    • Exhibit 50: Aspen Pharmacare Holdings Limited – Head News
    • Exhibit 51: Aspen Pharmacare Holdings Limited – Key Offerings
    • Exhibit 52: Aspen Pharmacare Holdings Limited – Segment Focus
  • 11.4 Baxter International Inc.
    • Exhibit 53: Baxter International Inc. – Observation
    • Exhibit 54: Baxter International Inc. – business segment
    • Exhibit 55: Baxter International Inc. – Major Offers
    • Exhibit 56: Baxter International Inc. – segment focus
  • 11.5 Christian Company Limited
    • Exhibit 57: Christian Company Limited – Overview
    • Exhibit 58: Christian Company Limited – Business Section
    • Exhibit 59: Christian Company Limited – Key Offerings
    • Exhibit 60: The Christian Company. Limited – Segment Focus
  • 11.6 Fresenius SE & Co. KGaA
    • Exhibit 61: Fresenius SE & Co. KGAA – Overview
    • Exhibit 62: Fresenius SE and Company KGA – Business Section
    • Exhibit 63: Fresenius SE and Company KGA – Major Offerings
    • Exhibit 64: Fresenius SE & Co. KGA – Segment Focus
  • 11.7 Hikma Pharmaceuticals Plc
    • Exhibit 65: Hikma Pharmaceuticals PLC – Overview
    • Exhibit 66: Hikma Pharmaceuticals PLC – Business Segment
    • Exhibit 67: Hikma Pharmaceuticals Plc – Main News
    • Exhibit 68: Hikma Pharmaceuticals Plc – Key Offerings
    • Exhibit 69: Hikma Pharmaceuticals PLC – Segment Focus
  • 11.8 Rovi SA Pharmaceutical Laboratories
    • Exhibit 70: Laboratories Pharmaceuticals Rovi SA – Overview
    • Exhibit 71: Laboratories Pharmacies Rovi SA – Business Section
    • Exhibit 72: Laboratories Pharmacies Rovi SA – Key Offerings
    • Exhibit 73: Laboratories Pharmaceuticals Rovi SA – Segment Focus
  • 11.9 Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd
    • Exhibition 74: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd – Overview
    • Exhibition 75: Nanjing Kingfriend Biochemical Pharmaceutical Co., Ltd. – Products and Services
    • Exhibition 76: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd – Major Offerings
  • 11.10 Pfizer Inc.
    • Exhibit 77: Pfizer Inc. – Overview
    • Exhibit 78: Pfizer Inc. – business segment
    • Exhibit 79: Pfizer Inc. – Top News
    • Exhibit 80: Pfizer Inc. – Major Offers
    • Exhibit 81: Pfizer Inc. – segment focus
  • 11.11 Sanofi SA
    • Exhibit 82: Sanofi SA – Overview
    • Exhibit 83: Sanofi SA – Professional Section
    • Exhibit 84: Sanofi SA.- Top News
    • Exhibit 85: Sanofi SA – Major Offerings
    • Exhibit 86: Sanofi SA – Segment Focus
  • 11.12 Viatris Inc.
    • Exhibit 87: Viatris Inc. – Observation
    • Exhibit 88: Viatris Inc. – business segment
    • Exhibit 89: Viatris Inc. – Top News
    • Exhibit 90: Viatris Inc. – Major Offers
    • Exhibit 91: Viatris Inc. – segment focus

12 Appendix

  • 12.2 US$. currency conversion rates for
    • Exhibit 92: US$ . currency conversion rates for
  • 12.3 Research Methodology
    • Exhibit 93: Research Methodology
    • Exhibit 94: Verification Techniques Employed for Market Sizing
    • Exhibit 95: Information Sources
  • 12.4 List of Abbreviations
    • Exhibit 96: List of Abbreviations

about us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market position. With over 500 specialized analysts, Technavio’s report library includes over 17,000 reports and counting, covering 800 technologies spread across 50 countries. Their customer base includes enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s extensive coverage, extensive research and actionable market insights to identify opportunities in existing and potential markets and assess their competitive position within changing market scenarios.

contact

Technavio Research
Jessie Flour
Media and Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
E-mail: [email protected]
Website: www.technavio.com/

source technavio

Leave a Reply

Your email address will not be published.